Stay updated with breaking news from Systemic jia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
1. Time to disease flare was significantly shorter in the placebo group versus baricitinib. 2. There was no difference in serious adverse events between the baricitinib and placebo groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Juvenile idiopathic arthritis (JIA) is defined by the onset of polyarticular joint pain before age 16 and can severely ....